Novel testing methods for endocrine disruption linked to developmental neurotoxicity

ENDpoiNTs final conference

Welcome to the ENDpoiNTs final conference

Read More


This second animation shows the first results of the ENDpoiNTs project and introduces the battery of novel testing methods.

Read More

Our Research

To develop an integrated platform of in vivo, in vitro and in silico methods for testing chemicals for ED properties impacting on neurodevelopment.

Read More


EURION Annual Cluster Meeting (5 Febr. 2020) and ENDpoiNTs Progress Meeting (6-7 Febr 2020)

Read More

The European project ENDpoiNTs will develop new testing and screening methods to identify endocrine disrupting chemicals (EDCs) that induce human developmental  neurotoxicity (DNT). Clear evidence supports associations between endocrine disrupting chemical (EDC) exposure and impaired neurodevelopment. Yet, current hazard assessment of EDCs does not address developmental neurotoxicity. This is due to lack of scientific knowledge on how endocrine disruption is linked to developmental neurotoxicity (DNT). Thus there is an urgent need for novel testing and screening tools to address ED-induced DNT, based on new scientific knowledge.